For the Quarter Ending December 2025
APAC
• In China, the Calcium Acetate Price Index fell by 3.34% quarter-over-quarter, reflecting softer feedstock costs.
• The average Calcium Acetate price for the quarter was USD 820.00/MT, reflecting FOB Shanghai conditions.
• Compliance retrofits trimmed capacity, tightening spot pools and notably lifting the Calcium Acetate Spot Price.
• Calcium Acetate Production Cost Trend rose as glacial acetic acid and utilities increased conversion expenses.
• Calcium Acetate Demand Outlook remained balanced with pharmaceutical restocking, food preservation needs, and stable export enquiries.
• Shanghai inventory draws narrowed volumes, lifting the Calcium Acetate Price Index and firming FOB offers.
• Calcium Acetate Price Forecast suggests modest upside early 2026 driven by restocking and export demand.
• Operational resilience at coastal plants-maintained supply continuity despite limited inland retrofit shutdowns, trimming capacity.
Why did the price of Calcium Acetate change in December 2025 in APAC?
• Higher glacial acetic acid, utility tariffs raised conversion costs, prompting firms to raise FOB offers.
• Blue Sky environmental inspections and retrofit-driven inland shutdowns reduced spot availability, tightening domestic supply pools.
• Sustained export enquiries and pharmaceutical restocking supported demand, offsetting balanced domestic consumption declines.
Europe
• In Europe, the Calcium Acetate Price Index declined quarter-over-quarter, tracking softer upstream cost pass-through from Asian suppliers and easing freight pressures.
• Calcium Acetate market conditions were shaped by import-led supply, with ample arrivals from Asia and stable port operations supporting availability across key consuming regions.
• Calcium Acetate Spot Price sentiment remained subdued, as buyers delayed purchases amid sufficient inventories and cautious downstream demand.
• Calcium Acetate Production Cost Trend for European consumers remained steady, with lower CIF costs partially offset by regulatory compliance, storage, and inland logistics expenses.
• Calcium Acetate Demand Outlook stayed balanced, supported by pharmaceutical formulation needs and food preservation demand, while industrial consumption remained stable.
• Inventory levels across European ports and distributor warehouses were comfortable, limiting near-term price recovery despite periodic spot enquiries.
• Calcium Acetate Price Forecast indicates limited upside in early 2026, with any recovery tied to restocking activity and changes in Asian supply discipline.
• Supply continuity remained intact, as diversified sourcing and stable shipping schedules reduced exposure to regional production disruptions.
Why did the price of Calcium Acetate change in December 2025 in Europe?
• Softer import costs and stable freight conditions reduced landed-cost pressure for European buyers.
• Adequate inventories and uninterrupted import flows limited urgency in spot procurement.
• Steady pharmaceutical and food-grade demand provided a floor, but was insufficient to drive a strong rebound amid cautious buying behavior.
North America
• In North America, the Calcium Acetate Price Index showed mild quarter-over-quarter softness, reflecting easing upstream cost pressure from international suppliers and improved shipment scheduling.
• Calcium Acetate market conditions remained import-led, with buyers largely dependent on Asian-origin material and contract-based inflows shaping regional availability.
• Calcium Acetate Spot Price movement remained mixed, as adequate port arrivals offset localized tightness caused by intermittent logistics delays and distributor inventory rotation.
• Calcium Acetate Production Cost Trend for importers stabilized overall, as lower feedstock-linked import values were partially offset by inland freight, warehousing, and compliance-related handling costs.
• Calcium Acetate Demand Outlook stayed balanced, supported by steady pharmaceutical consumption, food preservation demand, and consistent industrial end-use requirements.
• Calcium Acetate Price Index movement reflected cautious buyer behavior, with downstream players aligning purchases closely to near-term needs amid sufficient supply coverage.
• Distributor inventories in the USA covered approximately five to six weeks, limiting urgency-driven restocking and containing upward price momentum.
• Calcium Acetate Price Forecast points to limited near-term volatility, with pricing direction expected to track import cost movements and pharmaceutical procurement cycles into early 2026.
Why did the price of Calcium Acetate change in December 2025 in North America and the USA?
• Softer import replacement costs from Asia eased landed-cost pressure, contributing to a subdued pricing environment.
• Stable but occasionally delayed port logistics influenced spot availability, creating localized firmness without broader supply disruption.
• Steady pharmaceutical and food-grade demand supported baseline procurement, preventing a sharper downside despite cautious buying sentiment.
For the Quarter Ending September 2025
APAC
• In China, the Calcium Acetate Price Index fell by 2.61% quarter-over-quarter, pressured by elevated inventories.
• The average Calcium Acetate price for the quarter was approximately USD 882.33/MT, reflecting weak demand.
• Calcium Acetate Spot Price softened as exporters offered discounts to clear inventories and overseas buying.
• Calcium Acetate Price Forecast signals recovery in Q4, contingent on restocking and sustained export improvement.
• Calcium Acetate Production Cost Trend eased as acetic acid and calcium carbonate prices moderated recently.
• Calcium Acetate Demand Outlook remains muted overseas while domestic pharmaceutical demand shows gradual, cautious improvement.
• High inventories, slower overseas orders pushed the Calcium Acetate Price Index down amid logistical improvements.
• Major Chinese producers maintained output, but elevated stocks and cautious buyers limited upward price movement.
Why did the price of Calcium Acetate change in September 2025 in APAC?
• Excess inventories pressured offers as overseas orders declined, creating a clear supply overhang in September.
• Lower acetic acid and calcium carbonate costs reduced production costs, enabling sellers to lower prices.
• Rising freight volatility and currency movements affected export competitiveness, prompting cautious procurement, subdued buying internationally.
Europe
• In the Netherlands, the Calcium Acetate Price Index declined quarter-over-quarter, influenced by weaker import quotations from Asian suppliers and steady local availability.
• Calcium Acetate Spot Price softened as competitive offers from China and India persisted, while moderate freight conditions supported stable import flows.
• Calcium Acetate Price Forecast indicates a gradual stabilization through early Q4, supported by potential restocking and renewed activity in downstream pharmaceutical and food segments.
• Calcium Acetate Production Cost Trend for importers remained moderate, as lower raw material costs from Asia continued to ease landed import prices.
• Calcium Acetate Demand Outlook stayed cautious, with subdued pharmaceutical procurement and restrained industrial consumption limiting large-volume transactions.
• Price Index movements reflected oversupply from global producers, favorable freight trends, and currency shifts affecting import parity across the European market.
• Distributor inventories remained ample, reducing short-term restocking urgency and dampening buying sentiment during the quarter.
• Consistent import supply from Asia maintained smooth availability across ports, supporting stable trade conditions despite weak consumption trends.
Why did the price of Calcium Acetate change in September 2025 in Europe and the Netherlands?
• Lower Asian export quotations and high distributor inventories weighed on landed import prices, keeping domestic values under pressure.
• Soft demand from pharmaceutical and industrial buyers limited restocking activity, curbing upward pricing momentum.
• Stable freight and moderate currency movements helped maintain steady import flow but prevented any significant price recovery.
North America
• In the USA, the Calcium Acetate Price Index declined quarter-over-quarter, influenced by lower import quotations and steady availability from Asian suppliers.
• Calcium Acetate Spot Price softened as competitive offers from China and India, along with stable logistics, pressured landed values.
• Calcium Acetate Price Forecast indicates mild stabilization ahead, supported by expected restocking and gradual improvement in downstream consumption.
• Calcium Acetate Production Cost Trend for importers remained moderate as falling raw material costs in Asia lowered landed import prices.
• Calcium Acetate Demand Outlook stayed subdued, with limited pharmaceutical restocking and moderate industrial buying activity through the quarter.
• Price Index movements were largely shaped by global oversupply conditions, stable freight, and currency fluctuations affecting import parity.
• Distributor inventories remained adequate, with buyers exercising caution amid uncertain short-term price direction and soft regional demand.
• Consistent import flow from Asian producers sustained supply continuity, reducing price volatility across U.S. markets.
Why did the price of Calcium Acetate change in September 2025 in North America?
• Lower export offers from Asian producers and steady freight rates reduced landed costs, softening domestic price levels.
• Elevated inventories across distributors and limited restocking activity constrained demand, pressuring spot market quotations.
• Stable logistics and currency-driven cost adjustments maintained smooth import flow but restricted any immediate price recovery momentum.
For the Quarter Ending June 2025
North America
• Calcium Acetate Price Index in the US exhibited a consistent downward trend throughout Q2 2025, although the rate of decline moderated by June amid marginal stabilization in demand and easing freight volatility.
• In June, market conditions appeared less bearish as distributors began limited restocking, and input costs for acetic acid and calcium carbonate plateaued, slightly reducing the cost-pressure on producers.
• May recorded the steepest price drop of the quarter, driven by prolonged weak demand from the pharmaceutical and food sectors, along with excess inventories that forced sellers to offer deeper discounts to sustain volume flow.
• Competitive pressure from Asian-origin imports intensified in May, as lower FOB offers from China undercut domestic pricing despite elevated trans-Pacific freight rates.
• April’s decline was influenced by soft procurement sentiment, especially from contract manufacturers and food additive processors, who delayed purchases in expectation of lower price floors.
• The Calcium Acetate Production Cost Trend declined moderately over the quarter due to a favorable shift in raw material pricing and more stable energy costs, particularly across the Gulf Coast.
• Calcium Acetate Demand Outlook remained muted across Q2, though slight improvements in June indicated potential restocking by nutraceutical and pharma players ahead of anticipated Q3 requirements.
• Inventory levels were high through April and May but began tapering slightly in June due to improved logistics and modest pickup in domestic off-take.
• Suppliers responded to demand-side weakness by adjusting contract terms and offering flexible delivery schedules to retain long-term buyers.
• Calcium Acetate Price Forecast for early Q3 suggests marginal recovery potential contingent on sustained procurement, reduced inventory burden, and steady freight environment.
Europe
• Calcium Acetate Price Index in Europe, particularly in Germany, remained on a downward trajectory throughout Q2 2025, although the pace of decline eased by June amid stabilizing input costs and marginal improvement in regional demand.
• In June, the market showed signs of bottoming out, with prices declining at a slower rate as energy and raw material costs leveled off and offtake from the pharmaceutical and food processing sectors slightly improved.
• May registered a steeper drop in prices due to prolonged demand weakness, high inventory pressure, and competition from lower-priced Asian imports, particularly from China and India.
• Elevated freight rates and soft euro exchange rates further eroded the landed cost advantage for regional suppliers, prompting discounting to maintain competitiveness.
• In April, prices began trending lower following a buildup in inventories across distributors, compounded by sluggish consumption and easing feedstock costs for Acetic Acid and Calcium Carbonate.
• Calcium Acetate Production Cost Trend declined steadily through Q2, reflecting the broader European energy price softening and improved plant utilization rates in Western and Central Europe.
• Calcium Acetate Demand Outlook in Germany remained weak but showed tentative recovery signs in June as macroeconomic indicators pointed to modest industrial rebound and early restocking among food additive and pharmaceutical buyers.
• Inventory levels across the quarter remained high, although destocking activity accelerated in June in anticipation of firmer procurement needs for Q3.
• Calcium Acetate Suppliers maintained flexible pricing strategies across the quarter to protect market share, often revising contract quotes based on monthly cost movements and import parity.
• Calcium Acetate Price Forecast for early Q3 indicates potential price stabilization if current energy trends persist and downstream consumption gradually picks up.
APAC
• Calcium Acetate Price Index in China declined throughout Q2 2025, with a sharp fall in May followed by a more modest dip in June, reflecting sustained bearish market conditions.
• In April, prices fell slightly due to persistent oversupply, weak export volumes, and lower Acetic Acid costs that reduced production expenses.
• May saw a significant price drop of over 5%, as excess inventory from pre-holiday stockpiling met with weak downstream demand and reduced offtake across pharmaceuticals and food sectors.
• Calcium Acetate Suppliers in May aggressively cut prices to liquidate stock amid muted response to temporary tariff relief and rising freight costs to Western markets.
• In June 2025, the Spot Price for Calcium Acetate USP was assessed at USD 886/MT FOB Shanghai, marking a 0.67% decrease from May, primarily driven by high inventory levels and lower production costs.
• Calcium Acetate Production Cost Trend declined consistently over the quarter, with falling feedstock prices and softening manufacturing input costs creating margin room for producers to adjust prices downward.
• Calcium Acetate Demand Outlook remained weak across Q2, with subdued international orders for three straight months and only marginal improvements in domestic consumption.
• Export competitiveness weakened due to depreciation of the US Dollar against the Chinese Yuan, raising the relative cost of Chinese-origin products for overseas buyers.
• Inventory levels stayed elevated throughout the quarter, with limited improvement in offtake despite stable domestic manufacturing and easing logistics bottlenecks.
• Calcium Acetate Price Forecast for July suggests a potential rebound, driven by anticipated restocking activity, a possible slowdown in production, and early signs of stabilization in overseas inquiries.
For the Quarter Ending March 2025
North America
The North American Calcium Acetate market displayed fluctuating pricing trends in Q1 2025, shaped by shifting supply conditions, varied demand from key industries, and external economic factors. January began with a price surge, supported by strong demand from the pharmaceutical and food sectors, as well as logistical disruptions that increased delivery times and procurement costs. Port congestion, especially at major hubs like the Port of Los Angeles, coupled with elevated freight rates, strained supply chains and added to the pressure on pricing levels, maintaining market stability despite some challenges.
February saw a shift in market conditions, with prices fluctuating as domestic suppliers faced pressure from excess inventory levels. The softer demand from downstream sectors, coupled with a reduction in freight rates and improved supply availability, resulted in a more balanced market. The relatively stable production costs from key exporting regions allowed suppliers to offer more competitive prices, though ongoing uncertainty around trade policies, particularly with China, contributed to market caution. Buyers adopted a more measured approach, focused on inventory management.
March continued the trend of price fluctuations as the market faced ongoing supply chain challenges and evolving demand patterns. Although freight costs eased further, the imposition of new tariffs and uncertainties around international trade relations added volatility to the market. A slight uptick in industrial demand, particularly from the healthcare sector, provided some price support. However, reduced purchasing activity in other sectors, coupled with fluctuating raw material costs, created a mixed market sentiment, resulting in continued price instability. Overall, Q1 2025 in North America reflected a market in flux, with prices responding to a complex mix of supply pressures, shifting demand, and global trade uncertainties.
Asia Pacific
The Chinese Calcium Acetate export market saw fluctuating pricing trends throughout Q1 2025, primarily influenced by supply-demand dynamics and geopolitical factors. In January, the market experienced downward pressure as weak downstream demand, particularly in the pharmaceutical, healthcare, and food sectors, kept export prices subdued. High inventory levels and limited procurement activity resulted in a softening price environment, with international buyers delaying purchases. This, combined with China's deflationary economic conditions and seasonal fluctuations linked to the Lunar New Year, left the market struggling to recover. Geopolitical uncertainties, including potential tariffs under the incoming U.S. administration, further complicated the outlook, as suppliers engaged in aggressive destocking to clear excess inventory.
February marked a shift in the market as export prices rose due to tightening supply conditions. A reduction in domestic inventory, rising raw material costs, and the 10% tariff increase on Chinese goods bound for the U.S. contributed to heightened volatility. These factors prompted buyers to bulk purchase in anticipation of trade disruptions, while robust demand from the cosmetic and pharmaceutical sectors bolstered market conditions. Manufacturing activity showed signs of recovery, further supporting upward price pressure as China’s PMI indicated a rebound in factory output.
In March, the upward trend continued, driven by tightening supply conditions and strong industrial demand. The combination of lower inventories, robust procurement from key sectors, and rising upstream costs, particularly for Calcium Carbonate, placed pressure on production and supply chains. Although a slight decrease in China’s CPI indicated easing inflation, strong industrial demand, coupled with improved export competitiveness due to reduced freight costs, helped sustain the upward pricing momentum. The U.S. tariffs continued to encourage precautionary purchasing from international buyers, further tightening supply conditions and reinforcing the bullish sentiment in the Calcium Acetate market.
Overall, Q1 2025 saw a shift from a bearish to a more bullish pricing environment as supply-side constraints, strong sectoral demand, and geopolitical risks influenced market dynamics.
Europe
The European Calcium Acetate market, with Germany as a central player, experienced fluctuating price movements throughout Q1 2025, influenced by a combination of supply-side factors, demand shifts, and macroeconomic dynamics. January saw a modest price uptick, driven by early procurement strategies from the pharmaceutical and food sectors, which aimed to secure inventory ahead of expected disruptions due to the Lunar New Year holiday in Asia. Logistical constraints, such as port congestion and extended lead times, coupled with stable demand, helped maintain a generally balanced market despite the added cost pressures from increased freight rates.
In February, the market saw a reversal in pricing trends, with prices softening due to a reduction in downstream demand and improving supply chain conditions. The combination of high inventory levels from pre-holiday stockpiling and declining freight costs contributed to more favorable procurement conditions. Additionally, the stronger euro added to import cost relief, allowing European buyers to manage costs more efficiently. However, cautious purchasing behavior across the pharmaceutical and food industries, driven by broader economic uncertainties, contributed to a more competitive pricing environment.
By March, the market exhibited further price fluctuations, marked by continued soft demand and reduced purchasing activity. Despite ongoing logistical improvements, the weakening euro and trade policy disruptions created a more uncertain market backdrop. Supplier responses to these conditions included offering more competitive prices to move stock, but overall demand remained subdued. Lower raw material costs from key export markets provided some support, but the impact of oversupply and weakened buyer sentiment continued to temper any significant price shifts. Overall, Q1 2025 in Europe showed a progression from early stability to a more cautious market dynamic, marked by price fluctuations in response to fluctuating demand and macroeconomic influences.
